Opioid-induced Bowel Dysfunction
📧 Sign up to get email alerts when something new happens for Opioid-induced Bowel Dysfunction.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-04-26Clinical Trial Update: The Influence of Tramadol on Opioid-induced Bowel Dysfunction [Phase 2]
A Phase 2 clinical trial update evaluating the effect of tramadol on opioid-induced bowel dysfunction and associated constipation; the study…
-
CLINICAL_TRIALS trial_result · 2024-03-28Clinical Trial Update: The Effect of Naldemedine on Opioid-induced Bowel Dysfunction [Phase 2]
Phase 2 clinical trial update evaluating naldemedine for opioid-induced bowel dysfunction and constipation.
-
CLINICAL_TRIALS trial_result · 2019-12-30Clinical Trial Update: Opioid-induced Bowel Dysfunction: Long-Term Assessment of Lubiprostone [Phase 3]
Phase 3 long-term assessment trial of lubiprostone for opioid-induced bowel dysfunction has completed; results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-12-24Clinical Trial Update: Opioid-induced Bowel Dysfunction (OBD) Pivotal Assessment of Lubiprostone (OPAL) [Phase 3]
Phase 3 pivotal assessment for lubiprostone in opioid-induced bowel dysfunction completed with results posted.
-
CLINICAL_TRIALS trial_result · 2017-08-22Clinical Trial Update: Study of Alvimopan for the Management of Opioid-induced Postoperative Bowel Dysfunction/Postoperative Ileus [Phase 3]
A Phase 3 study of alvimopan for managing opioid-induced postoperative bowel dysfunction and postoperative ileus has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-05-30Clinical Trial Update: Study to Evaluate the Safety and Efficacy of Naldemedine (S-297995) for the Treatment of Opioid-Induced Bowel Dysfunction in Subjects With Chronic Pain [Phase 2]
Phase 2 study evaluating the safety and efficacy of naldemedine (S-297995) for treating opioid-induced bowel dysfunction in chronic pain pat…
-
CLINICAL_TRIALS trial_result · 2016-02-03Clinical Trial Update: Opioid-induced Bowel Dysfunction: Pivotal Assessment of Lubiprostone [Phase 3]
Phase 3 trial assessment of lubiprostone for opioid-induced bowel dysfunction has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2016-01-11Clinical Trial Update: Study of Alvimopan for the Management of Opioid-induced Postoperative Bowel Dysfunction/Postoperative Ileus [Phase 3]
Phase 3 study of alvimopan for opioid-induced postoperative bowel dysfunction and postoperative ileus has completed, per trial update.
-
CLINICAL_TRIALS trial_result · 2015-12-07Clinical Trial Update: Opioid-induced Bowel Dysfunction Pivotal Assessment of Lubiprostone [Phase 3]
A Phase 3 pivotal trial assessing lubiprostone for opioid-induced bowel dysfunction has completed with results posted in 2015.
-
CLINICAL_TRIALS trial_result · 2015-09-02Clinical Trial Update: Study 767905/008 Extension Study: Alvimopan for Treatment of Opioid-Induced Bowel Dysfunction in Cancer Pain Subjects [Phase 2]
This document reports the completion of the Phase 2 extension study of alvimopan for opioid-induced bowel dysfunction in cancer pain subject…
-
CLINICAL_TRIALS trial_result · 2015-07-20Clinical Trial Update: Study of Alvimopan for the Management of Opioid-induced Postoperative Bowel Dysfunction/Postoperative Ileus [Phase 3]
Phase 3 clinical trial of alvimopan for opioid-induced postoperative bowel dysfunction/postoperative ileus has completed.